0001863964-21-000001.txt : 20210524 0001863964-21-000001.hdr.sgml : 20210524 20210524130821 ACCESSION NUMBER: 0001863964-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210524 DATE AS OF CHANGE: 20210524 EFFECTIVENESS DATE: 20210524 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bioverge Funds, HepaTx I, LLC CENTRAL INDEX KEY: 0001863964 IRS NUMBER: 854294963 STATE OF INCORPORATION: ID FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-400369 FILM NUMBER: 21952808 BUSINESS ADDRESS: STREET 1: 222 N 13TH ST. CITY: BOISE STATE: ID ZIP: 83702 BUSINESS PHONE: 2086961262 MAIL ADDRESS: STREET 1: C/O LOON CREEK CAPITAL STREET 2: PO BOX 6088 CITY: BOISE STATE: ID ZIP: 83707 D 1 primary_doc.xml X0708 D LIVE 0001863964 Bioverge Funds, HepaTx I, LLC 222 N 13TH ST. BOISE ID IDAHO 83702 2086961262 IDAHO None None Limited Liability Company true 2020 Neil - Bioverge Funds Management, LLC - Littman 237 Kearny Street #9171 San Francisco CA CALIFORNIA 94108 Executive Officer Investing Not Applicable 06b false 2021-05-20 false true false 1500 Bioverge Funds Management, LLC None None None 237 Kearny Street #9171 San Francisco CA CALIFORNIA 94108 CA CALIFORNIA false 150000 128436 21564 false 10 0 0 5000 true false Bioverge Funds, HepaTx I, LLC Neil J Littman Neil J Littman Manager of the Issuer?s Manager 2021-05-24